![]() Amniocentesis had been performed on voluntary basis, and the uptake rate of amniocentesis following a positive Down’s syndrome screening was 104 in 119 cases (87.3%). Results: There were 119 in 999 cases (11.9%) of the triple test positive. The risk cut-off for Down’s syndrome is one in 250 or greater, based on software for prenatal Down’s syndrome risk calculation, by Prisca 3.5 DPC. Material and Method: The uptake of screening was 999 in 1,040 women (96.0%), between 14 to 20 weeks of gestation with the triple markers: Alpha-fetoprotein (AFP), human Chorionic Gonadotropin (hCG), and unconjugated Estriol (uE3) by Immulite chemiluminescent immunoassay system, Diagnostic Product Corporation (DPC). ![]() Setting: The Hat Yai MSS program between 16 February 2003 and 11 March 2004. Objectives: To summarize the experience and evaluate the performance of the Hat Yai maternal serum screening (MSS) program.
0 Comments
Leave a Reply. |